Trial
NCT03136406
QUILT-3.039: NANT Pancreatic Cancer Vaccine: Combination Immunotherapy in Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
ImmunityBio, Inc.
Collaborators
—
Condition
Pancreatic Cancer
Intervention
Cyclophosphamide
Why stopped
Study halted prematurely and will not resume; participants are no longer being examined or receiving intervention
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-06-11